Diflorasone
From Wikipedia, the free encyclopedia
| Image:Diflorasone.png | |
|
Diflorasone
|
|
| Systematic (IUPAC) name | |
| [17-(2-acetyloxyacetyl)- 6,9-difluoro-11-hydroxy- 10,13,16-trimethyl-3-oxo- 6,7,8,11, 12,14,15,16- octahydrocyclopenta[a] phenanthren-17-yl] acetate | |
| Identifiers | |
| CAS number | 1-13-8 |
| ATC code | D07AC10 |
| PubChem | 71414 |
| DrugBank | APRD00921 |
| Chemical data | |
| Formula | C26H32F2O7 |
| Mol. weight | 494.525 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Diflorasone is a corticosteroid.
 |
This medical treatment article is a stub. You can help Wikipedia by expanding it. |
